Identification of RALA as a Therapeutic Target and Prognostic Predictor of Osteosarcoma.
Gentao FanYan ZhuHao ZhuLingfeng YuZhen WangChenjun ZhaiGuangxin ZhouJianning ZhaoYi Cun WangPublished in: BioMed research international (2023)
We identified RALA as an oncogene in OS, and RALA upregulation in a concerted manner with ABCE1 was significantly associated with worse outcomes of OS patients. Targeting RALA may prove to be a novel target for OS immunotherapy in future clinical practice.